Short CV/Education and training

  • 1990 – 1992
    University Göttingen, Germany (Biology)

  • 1992 – 1994
    University Hamburg, Germany (Biology)

  • 1994 – 1995
    Diploma thesis, University Hamburg, Germany

  • 1996 – 1998
    PhD thesis, University Hannover and Medical School Hannover, Germany

  • 1998 – 1999
    Postdoctoral Fellow, Fraunhofer-Institute for Toxicology and Aerosol Research, Hannover, Germany

  • 1999 – 2004
    Postdoctoral Fellow, Departments of Genetics and Pediatrics, School of Medicine, Stanford University, USA

  • 2004 – 2005
    Research Associate, Departments of Genetics and Pediatrics, School of Medicine, Stanford University, USA

  • 2005 – 2011
    Group leader funded by the SFB 455, Department of Virology, Max von Pettenkofer-Institute, Ludwig-Maximilians-University Munich, Germany

  • Since 2011
    W3 Professorship, Chair Virology and Microbiology, University Witten Herdecke, Germany

Selected publications

  • Häusl, M.; Zhang, W.; Müther, N.; Rauschhuber, C.; Franck, H.W.; Nichols, T.C.; Kay, M.A.; Ehrhardt, A. (2010): A hyperactive transposase system enables persistent phenotypic correction in large animals. In: Molecular Therapy, 8:1896-906.

  • Jager, L.; Häusl, M.; Rauschhuber, C.; Wolf, N.; Ehrhardt, A. (2009): A rapid protocol for construction and production of helper-dependent adenoviral vectors. In: Nature Protocols, 4:547-64.

  • Ehrhardt, A.; Yant, S.R.; Giering, J.C.; Xu, H.; Engler, J.A.; Kay, M.A. (2007): Somatic integration from a novel adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo. In: Molecular Therapy 15:146-56.

  • Ehrhardt, A.; Xu, H.; Dillow, A.M.; Bellinger, D.A.; Nichols, T.; Kay, M.A. (2003): A Gene Deleted Adenoviral Vector Results in Phenotypic Correction of Hemophilia B in a Canine Model Without Toxicity. In: Blood 102:2403-11.

  • Thomas, C.E.; Ehrhardt, A.; Kay, M.A. (2003): Viral Pharmacology: Progress and Problems in Engineering Viral Vectors for Gene Therapy. Review article, in: Nature Reviews Genetics, 4: 348-358.


Selected projects

  • EU – Framework Programme 7, Persistent transgenesis

  • DFG Priority Programme – SPP 1230, Evaluation and delivery of various improved recombinases into mammalian cells with viral vectors for long-term and stable transgene expression levels

  • DFG Priority Programme – SFB 455, Stability of adenoviral vector genomes

  • Wilhelm Sander-Foundation: Preclinical evaluation of novel viral vectors fort he development of novel liver-based therapy approaches for hemophilia B

Membership in scientific bodies/juries

  • Member of the editorial board of the Journal Human Gene Therapy

  • German Society of Virology, Head of Study Group 'Viral Vectors and Gene Therapy'

  • Committee: Viral Gene Transfer Vectors, American Society of Gene Therapy

Additional qualifications

  • Academic didactic training course on 'Problem-based Learning' in the framework of the München-Harvard Alliance, November 2007


Contact

You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here

Testimonials

  1. Read what our members say about AcademiaNet.

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Prof. Dr. Heike Allgayer

    Biology, Human medicine

  2. Prof. Avan Aihie Sayer

    Human medicine, Academic Medicine

  3. Prof. Patrizia Agostinis

    Biology, Human medicine, Cell Biology, Cellular signaling, Cancer biology, Cancer therapy

  4. Prof. Helen Arthur

    Human medicine, Role of TGFbeta signalling in cardiovascular development and heart repair